NeuroSense Therapeutics Ltd. Company Information
NeuroSense Therapeutics Ltd.'s employee growth, exchange listings and data sources
Key Information
- Name: NeuroSense Therapeutics Ltd.
- Ticker: NRSN
- Exchange: NasdaqCM
- Founded: 2017
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$17.524m
- Shares Outstanding: 19.47m
- Website: https://www.neurosense-tx.com
Number of Employees
Location
- NeuroSense Therapeutics Ltd.
- Building B
- 11 HaMenofim Street
- Herzliya
- 4672562
- Israel
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| NRSN | NasdaqCM (Nasdaq Capital Market) | Yes | Ordinary Shares | US | USD | Dec 2021 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/27 17:13 |
| End of Day Share Price | 2024/11/27 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.